US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Achieve Life Sciences Inc (ACHV)
Achieve Life Sciences Inc (ACHV) ニュース

ACHV

Achieve Life Sciences (ACHV)

Achieve Life Sciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ACHV

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	05 : 08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/05/10	05 : 01	GlobeNewswire Inc.	Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/05/07	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/05/07	00 : 16	GlobeNewswire Inc.	Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/04/25	21 : 00	GlobeNewswire Inc.	Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/04/11	21 : 00	GlobeNewswire Inc.	Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/03/29	05 : 01	GlobeNewswire Inc.	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/03/20	21 : 00	GlobeNewswire Inc.	Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/03/14	21 : 00	GlobeNewswire Inc.	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/03/07	06 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/03/07	06 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/03/01	06 : 41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/03/01	06 : 16	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/02/29	22 : 01	GlobeNewswire Inc.	Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/02/29	22 : 00	GlobeNewswire Inc.	Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/02/28	05 : 32	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/01/30	04 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/01/25	09 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/01/25	09 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/01/25	09 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/01/25	09 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/01/25	09 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/01/25	09 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/01/25	08 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/01/25	08 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2023/12/12	06 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACHV	Achieve Life Sciences Inc
2023/11/10	06 : 08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACHV	Achieve Life Sciences Inc
2023/11/10	06 : 00	GlobeNewswire Inc.	Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update	NASDAQ:ACHV	Achieve Life Sciences Inc
2023/10/26	21 : 00	GlobeNewswire Inc.	Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023	NASDAQ:ACHV	Achieve Life Sciences Inc
2023/10/03	21 : 00	GlobeNewswire Inc.	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences	NASDAQ:ACHV	Achieve Life Sciences Inc

Showing the most relevant articles for your search:NASDAQ:ACHV

1 2 3 4 5 6 7 8 9 10 次へ >>

Invesco QQQ Trust Series 1

US Dollar vs Sterling

Deutsche Telekom (QX)

Financial Select Sector

American Express

BNP Paribas (QX)

Verizon Communications

Health Care Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約